172 related articles for article (PubMed ID: 35088246)
1. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.
van Leeuwen M; Kieffer JM; Young TE; Annunziata MA; Arndt V; Arraras JI; Autran D; Hani HB; Chakrabarti M; Chinot O; Cho J; da Costa Vieira RA; Darlington AS; Debruyne PR; Dirven L; Doege D; Eller Y; Eichler M; Fridriksdottir N; Gioulbasanis I; Hammerlid E; van Hemelrijck M; Hermann S; Husson O; Jefford M; Johansen C; Kjaer TK; Kontogianni M; Lagergren P; Lidington E; Lisy K; Morag O; Nordin A; Al Omari ASH; Pace A; De Padova S; Petranovia D; Pinto M; Ramage J; Rammant E; Reijneveld J; Serpentini S; Sodergren S; Vassiliou V; Leeuw IV; Vistad I; Young T; Aaronson NK; van de Poll-Franse LV;
J Cancer Surviv; 2023 Aug; 17(4):1111-1130. PubMed ID: 35088246
[TBL] [Abstract][Full Text] [Related]
2. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire.
van Leeuwen M; Husson O; Alberti P; Arraras JI; Chinot OL; Costantini A; Darlington AS; Dirven L; Eichler M; Hammerlid EB; Holzner B; Johnson CD; Kontogianni M; Kjær TK; Morag O; Nolte S; Nordin A; Pace A; Pinto M; Polz K; Ramage J; Reijneveld JC; Serpentini S; Tomaszewski KA; Vassiliou V; Verdonck-de Leeuw IM; Vistad I; Young TE; Aaronson NK; van de Poll-Franse LV;
Health Qual Life Outcomes; 2018 Jun; 16(1):114. PubMed ID: 29866185
[TBL] [Abstract][Full Text] [Related]
3. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
[TBL] [Abstract][Full Text] [Related]
4. Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22).
Greimel E; Nagele E; Lanceley A; Oberguggenberger AS; Nordin A; Kuljanic K; Arraras JI; Wei-Chu C; Jensen PT; Tomaszewski KA; Creutzberg CL; Galalae R; Toelen H; Zimmermann K; Bjelic-Radisic V; Costantini A; Almont T; Serpentini S; Paskeviciute Frøding L; Vistad I; Schmalz C;
Eur J Cancer; 2021 Sep; 154():235-245. PubMed ID: 34298374
[TBL] [Abstract][Full Text] [Related]
5. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
[TBL] [Abstract][Full Text] [Related]
6. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
[TBL] [Abstract][Full Text] [Related]
7. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
8. International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer.
van Leeuwen M; Kieffer JM; Efficace F; Fosså SD; Bolla M; Collette L; Colombel M; De Giorgi U; Holzner B; van de Poll-Franse LV; van Poppel H; White J; de Wit R; Osanto S; Aaronson NK; ; ;
Health Qual Life Outcomes; 2017 May; 15(1):97. PubMed ID: 28490338
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
10. Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
Vachon H; Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Fortpied C; Flechtner HH; Vestmoe Maraldo M; Hutchings M; Meijnders P; Aleman B; Lugtenburg P; Spina M; André M; Hertzberg M; Briones J; Bottomley A;
Eur J Haematol; 2021 May; 106(5):697-707. PubMed ID: 33570765
[TBL] [Abstract][Full Text] [Related]
11. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors.
Husson O; Haak HR; Mols F; Nieuwenhuijzen GA; Nieuwlaat WA; Reemst PH; Huysmans DA; Toorians AW; van de Poll-Franse LV
Acta Oncol; 2013 Feb; 52(2):447-54. PubMed ID: 23013266
[TBL] [Abstract][Full Text] [Related]
12. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
[TBL] [Abstract][Full Text] [Related]
13. Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma.
Musoro JZ; Bottomley A; Coens C; Eggermont AM; King MT; Cocks K; Sprangers MA; Groenvold M; Velikova G; Flechtner HH; Brandberg Y;
Eur J Cancer; 2018 Nov; 104():169-181. PubMed ID: 30359910
[TBL] [Abstract][Full Text] [Related]
14. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
15. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
16. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC
J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390
[TBL] [Abstract][Full Text] [Related]
17. Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors.
Kurian CJ; Leader AE; Thong MSY; Keith SW; Zeigler-Johnson CM
BMC Public Health; 2018 Aug; 18(1):1060. PubMed ID: 30139347
[TBL] [Abstract][Full Text] [Related]
18. Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)-a report on phase III.
Niedeggen C; Singer S; Groth M; Petermann-Meyer A; Röth A; Schrezenmeier H; Höchsmann B; Brümmendorf TH; Panse J
Ann Hematol; 2019 Jul; 98(7):1547-1559. PubMed ID: 31115593
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: a German cohort study.
Ratjen I; Schafmayer C; Enderle J; di Giuseppe R; Waniek S; Koch M; Burmeister G; Nöthlings U; Hampe J; Schlesinger S; Lieb W
BMC Cancer; 2018 Nov; 18(1):1156. PubMed ID: 30466408
[TBL] [Abstract][Full Text] [Related]
20. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
Machingura A; Taye M; Musoro J; Ringash J; Pe M; Coens C; Martinelli F; Tu D; Basch E; Brandberg Y; Grønvold M; Eggermont A; Cardoso F; Van Meerbeeck J; van der Graaf WTA; Taphoorn M; Reijneveld JC; Soffietti R; Sloan J; Velikova G; Flechtner H; Bottomley A;
Eur J Cancer; 2022 Jul; 170():1-9. PubMed ID: 35569438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
